Repurposing approved treatments
We're taking the fastest route to better treatments by tracking down drugs approved and in use for other conditions, which could have potential for Parkinson's.
Developing a drug from scratch is a long, slow and expensive process. People with Parkinson's need better treatments now, so we're looking for shortcuts.
We're convinced there are already drugs available on pharmacy shelves with hidden benefits for Parkinson's.
For example, aspirin is one of the oldest drugs for treating fever and pain, but has recently been shown to have other powerful effects - such as reducing the risk of heart attacks and stroke.
By finding these drugs and moving them rapidly into clinical trials we'll make them available for people with Parkinson's much more quickly, easily and cheaply.
Repurposing drugs already used to treat other conditions
Dr Dilan Athauda at the UCL Institute of Neurology explains how repurposing drugs can help people with Parkinson's.
Trials to treatments: repurposed drugs
What if a diabetes drug could slow down Parkinson’s, or a dementia drug could reduce falls?
In this blog, we find out what drug repurposing means and take a look at drugs with potential for Parkinson’s that are already being tested in people in clinical trials.
About our research
Everything we do is driven by people affected by Parkinson's. That's why we're striving for new and better treatments - in years, not decades.
Find out how we're speeding up Parkinson's research and how you can get involved.